EUVIMEDOpdag EUVIMED
Crossref

Nano DDS Mediated Angiogenic Cell and Tissue Delivery

Kenichi Nagase

Drug Delivery System · 2026-07-25 · 41 (3) · 194-199

DOI: 10.2745/dds.41.194 ↗

At a glance

Journal article in Drug Delivery System, published on 2026-07-25. Written by Kenichi Nagase. 18 references.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Hepatocyte sheet transplantation has attracted attention as a novel therapeutic strategy for intractable liver diseases. The authors have developed basic fibroblast growth factor (bFGF)-releasing nanoparticles designed to promote vascularization within transplanted tissues and thereby enhance engraftment efficiency. By utilizing these nanoparticles, transplantation of hepatocyte sheets was successfully achieved. This review outlines the design strategy of the bFGF-containing nanoparticles.

Cite

APA

Nagase, K. (2026). Nano DDS Mediated Angiogenic Cell and Tissue Delivery. Drug Delivery System, 41(3), 194-199. https://doi.org/10.2745/dds.41.194

Vancouver

Nagase K. Nano DDS Mediated Angiogenic Cell and Tissue Delivery. Drug Delivery System. 2026;41(3):194-199. doi:10.2745/dds.41.194

BibTeX
@article{Nagase2026,
  author = {Nagase, Kenichi},
  title = {Nano DDS Mediated Angiogenic Cell and Tissue Delivery},
  journal = {Drug Delivery System},
  year = {2026},
  volume = {41},
  number = {3},
  pages = {194--199},
  doi = {10.2745/dds.41.194}
}
Start for free →